PHILADELPHIA -- An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.
A novel, investigational NaV1.8 sodium channel blocker known as VX-548 reduced acute pain after abdominoplasty or bunionectomy at the highest dose, but not at lower doses, two phase II trials showed.
Steven Poelzing (left) and Gregory Hoeker, researchers at the Fralin Biomedical Research Institute at VTC, collaborated on a new study published in the journal Heart Rhythm revealing why low blood ...
Nat Clin Pract Neurol. 2008;4(3):159-169. Drug Primary clinical use Protective effect during administration in animal models? Effects of withdrawal in EAE Clinical study Phenytoin Treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results